These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28760825)

  • 1. Modulation of the extent of structural heterogeneity in α-synuclein fibrils by the small molecule thioflavin T.
    Kumar H; Singh J; Kumari P; Udgaonkar JB
    J Biol Chem; 2017 Oct; 292(41):16891-16903. PubMed ID: 28760825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorph-specific distribution of binding sites determines thioflavin-T fluorescence intensity in α-synuclein fibrils.
    Sidhu A; Vaneyck J; Blum C; Segers-Nolten I; Subramaniam V
    Amyloid; 2018 Sep; 25(3):189-196. PubMed ID: 30486688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Mechanisms Determine α-Synuclein Fibril Morphology during Growth and Maturation.
    Sidhu A; Segers-Nolten I; Raussens V; Claessens MM; Subramaniam V
    ACS Chem Neurosci; 2017 Mar; 8(3):538-547. PubMed ID: 28292187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of α-Synuclein Amyloid Fibrils Using the Fluorescent Probe Thioflavin T.
    Sulatskaya AI; Rodina NP; Sulatsky MI; Povarova OI; Antifeeva IA; Kuznetsova IM; Turoverov KK
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein aggregation at low concentrations.
    Afitska K; Fucikova A; Shvadchak VV; Yushchenko DA
    Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):701-709. PubMed ID: 31096048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wildtype and A30P mutant alpha-synuclein form different fibril structures.
    Nielsen SB; Macchi F; Raccosta S; Langkilde AE; Giehm L; Kyrsting A; Svane AS; Manno M; Christiansen G; Nielsen NC; Oddershede L; Vestergaard B; Otzen DE
    PLoS One; 2013; 8(7):e67713. PubMed ID: 23861789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.
    Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA
    J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the non-fibrillar α-synuclein oligomers.
    Hong DP; Han S; Fink AL; Uversky VN
    Protein Pept Lett; 2011 Mar; 18(3):230-40. PubMed ID: 20858207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An α-Cyanostilbene Derivative for the Enhanced Detection and Imaging of Amyloid Fibril Aggregates.
    Marzano NR; Wray KM; Johnston CL; Paudel BP; Hong Y; van Oijen A; Ecroyd H
    ACS Chem Neurosci; 2020 Dec; 11(24):4191-4202. PubMed ID: 33226775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence-Based Monitoring of Early-Stage Aggregation of Amyloid-β, Amylin Peptide, Tau, and α-Synuclein Proteins.
    Li Y; Awasthi S; Bryan L; Ehrlich RS; Tonali N; Balog S; Yang J; Sewald N; Mayer M
    ACS Chem Neurosci; 2024 Sep; 15(17):3113-3123. PubMed ID: 39150403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical characterization of the G51D mutation of α-synuclein that is responsible for its severe cytotoxicity.
    Murata T; Tochio N; Utsunomiya-Tate N
    Neurosci Lett; 2021 Aug; 760():136077. PubMed ID: 34161822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins: implications for the mechanism of transmissible conformational diseases.
    Yagi H; Kusaka E; Hongo K; Mizobata T; Kawata Y
    J Biol Chem; 2005 Nov; 280(46):38609-16. PubMed ID: 16162499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent α-synuclein dimers: chemico-physical and aggregation properties.
    Pivato M; De Franceschi G; Tosatto L; Frare E; Kumar D; Aioanei D; Brucale M; Tessari I; Bisaglia M; Samori B; de Laureto PP; Bubacco L
    PLoS One; 2012; 7(12):e50027. PubMed ID: 23272053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity.
    Xu CK; Castellana-Cruz M; Chen SW; Du Z; Meisl G; Levin A; Mannini B; Itzhaki LS; Knowles TPJ; Dobson CM; Cremades N; Kumita JR
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dependence of alpha-synuclein aggregate morphology on solution conditions.
    Hoyer W; Antony T; Cherny D; Heim G; Jovin TM; Subramaniam V
    J Mol Biol; 2002 Sep; 322(2):383-93. PubMed ID: 12217698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heme Stabilization of α-Synuclein Oligomers during Amyloid Fibril Formation.
    Hayden EY; Kaur P; Williams TL; Matsui H; Yeh SR; Rousseau DL
    Biochemistry; 2015 Aug; 54(30):4599-610. PubMed ID: 26161848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsp90 inhibits α-synuclein aggregation by interacting with soluble oligomers.
    Daturpalli S; Waudby CA; Meehan S; Jackson SE
    J Mol Biol; 2013 Nov; 425(22):4614-28. PubMed ID: 23948507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities.
    Alam P; Bousset L; Melki R; Otzen DE
    J Neurochem; 2019 Sep; 150(5):522-534. PubMed ID: 31254394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and Characterization of Small Molecule Interactions with Fibrillar Protein Aggregates Using Microscale Thermophoresis.
    Fisher E; Zhao Y; Richardson R; Janik M; Buell AK; Aigbirhio FI; Tóth G
    ACS Chem Neurosci; 2017 Sep; 8(9):2088-2095. PubMed ID: 28640595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Synuclein Aggregation Intermediates form Fibril Polymorphs with Distinct Prion-like Properties.
    Mehra S; Ahlawat S; Kumar H; Datta D; Navalkar A; Singh N; Patel K; Gadhe L; Kadu P; Kumar R; Jha NN; Sakunthala A; Sawner AS; Padinhateeri R; Udgaonkar JB; Agarwal V; Maji SK
    J Mol Biol; 2022 Oct; 434(19):167761. PubMed ID: 35907572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.